Levodopa
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Agent Affecting Nervous System ->
Dopamine Agonist -> Levodopa
Levodopa Definition
An amino acid precursor of dopamine with antiparkinsonian properties. Levodopa is a prodrug that is converted to dopamine by DOPA decarboxylase and can cross the blood-brain barrier. When in the brain, levodopa is decarboxylated to dopamine and stimulates the dopaminergic receptors, thereby compensating for the depleted supply of endogenous dopamine seen in Parkinson's disease. To assure that adequate concentrations of levodopa reach the central nervous system, it is administered with carbidopa, a decarboxylase inhibitor that does not cross the blood-brain barrier, thereby diminishing the decarboxylation and inactivation of levodopa in peripheral tissues and increasing the delivery of dopamine to the CNS.
Levodopa Synonyms
Levodopa, (-)-3-(3,4-Dihydroxyphenyl)-L-alanine, (--)-2Amino-3-)3,4-dihydroxyphenyl)propanoic Acid, (--)-3-(3,4-Dihydroxyphenyl)-L-alanine, .beta.-(3,4-Dihydroxyphenyl)-L-alanine, 3-(3,4-Dihydroxyphenyl)-L-alanine, 3-Hydroxy-L-tyrosine, Bendopa, Cidandopa, Deadopa, Dopaflex, Dopaidan, Dopal, Dopalina, Dopar, Doparkine, Doparl, Dopasol, Dopaston, Dopastral, Doprin, Eldopal, Eldopar, Eldopatec, Eurodopa, L(-)-Dopa, L-.beta.-(3,4-Dihydroxyphenyl)alanine, L-DOPA, L-Dopa, LEVODOPA, Laradopa, Larodopa, Ledopa, Levopa, Maipedopa, Parda, Veldopa, beta-(3,4-Dihydroxyphenyl)-L-alanine
Terms in Levodopa category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.